Searched for
SYSTEMATIX SHARES
Consumer staples sector to face growth normalization in 2nd half of 2026, updates on pricing power and channel efficiency eyedConsumer staples growth momentum is likely to moderate in the second half of FY27 as GST-related benefits phase out and high base effects s...- Pushp Brand files IPO papers with SebiPushp Brand (India) is preparing for its initial public offering. The spice manufacturer plans to raise between Rs 800 crore and Rs 1,000 c...
- Can Suzlon Energy shares rally up to 31% after Q4 results? Top brokerages weigh inBrokerages remain largely bullish on Suzlon Energy after the renewable energy major reported strong revenue growth and improving execution ...
- Semaglutide race: Torrent grabs 38% market shareOver a dozen Indian companies have launched generic versions of the GLP1 drug used for diabetes and weight management since the expiry of N...
- SBI Q4 Preview: Can the largest PSB deliver good profits despite treasury pain?SBI is expected to report a subdued March quarter as treasury losses likely offset stable loan growth and resilient margins. Brokerages exp...
- EM is back, India is next: Why the 2025 underperformance is the perfect setup for a 2026 comebackEmerging Markets led global returns in 2025, but India lagged due to outflows and weaker earnings. With valuations correcting and domestic ...
- Drugs at your door: Signs of a disruption taking shape in IndiaIndia Pharmacy Retail Quick Commerce: India's medicine delivery is seeing a change. Quick-commerce apps are making it easier to buy medicin...
- Suzlon Energy shares jump 4%, extend gains for second session. Should you buy this renewable energy player?Suzlon Energy shares are soaring, driven by strong market sentiment and rising electricity demand forecasts. Analysts are bullish, citing r...
- Pharma stocks buck market weakness as Dr Reddy's gainsPharma stocks showed strength on Thursday, defying market weakness. Dr Reddy's Laboratories saw significant gains, fueled by anticipation o...
- FIIs increase stake in Suzlon Energy for third straight quarter. What’s keeping them interested?Foreign institutional investors have increased their stake in Suzlon Energy for the third consecutive quarter, signalling sustained confide...
- Earnings vs signals: Q4 results may matter more than they lookThe March quarter earnings season arrives at an inflection point, with stable numbers masking underlying economic shifts. Escalation of the...
- FIIs pick 1.68 crore shares in Suzlon Energy amid Rs 1 lakh crore outflows. What are they seeing?Foreign institutional investors (FIIs) quietly increased their exposure to Suzlon Energy in the March quarter, even as they pulled out more...
- Mounjaro sales dip amid price war as semaglutide generics gain groundMounjaro, the star pharmaceutical from Eli Lilly, is experiencing a downturn in sales across India. This slump can be attributed to competi...
- These 2 multibagger smallcap stocks to trade ex-split tomorrow. Do you own?Shares of Premier Polyfilm and Systematix Corporate Services will be focused today due to announced stock splits. Both companies set Novemb...
- Is it time to be a contra buyer in diagnostic stocks? Dhananjay Sinha answersSystematix Shares strategy head says that earnings estimates are starting to be revised on the downside, interest costs are rising, and pro...
- Buy State Bank of India, target Rs 285 : Systematix Shares & StockA recovery in business growth, strong cost containment focus, stabilising asset quality and adequate capitalization to result in SBI being ...
- Buy APL Apollo Tubes, target Rs 1195 : Systematix Shares & StockSystematix Shares & Stocks expectsthe company’s total revenue and net profit to grow by 8.4% and 28.3% respectively over FY16-18
- Buy Mahindra & Mahindra Ltd., target Rs 1750.0 : Systematix Shares & StockBuy Mahindra & Mahindra Ltd. at a price target of Rs 1750.0 and a stop loss at Rs 1420.0 from entry point
- Buy Eicher Motors Ltd., target Rs 28000.0 : Systematix Shares & StockBuy Eicher Motors Ltd. at a price target of Rs 28000.0 and a stop loss at Rs 20500.0 from entry point
- Buy Bank of Baroda, target Rs 229.0 : Systematix Shares & StockBuy Bank of Baroda at a price target of Rs 229.0 and a stop loss at Rs 128.0 from entry point
Load More
